AUPH Aurinia Pharmaceuticals Inc.
Nasdaq · SEC CIK 1600620 · EDGAR
- Bought, last 12 months
- $25.14M 2 purchases by 1 insiders
- Sold, last 12 months
- $546.4K 2 sales by 1 insiders
- Filings on record
- 132 since 2021-07-29, latest 2026-09-11 16:26
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| TANG KEVIN | Dir | $25.14M | — |
| Robertson Stephen P. | EVP, GC | — | $546.4K |
| Cole Ryan | COO | — | — |
| Keenan Greg | SVP, Chief Medical Off | — | — |
| Hearne Michael S | CFO | — | — |
| Miller Joseph M | CFO | — | — |
| Donley Matthew Maxwell | COO | — | — |
| Bailey Jeffrey Allen | Dir | — | — |
| Johnson Craig A | Dir | — | — |
| Greenleaf Peter | CEO, Dir | — | — |
Transactions 158
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-06 | 2023-03-02 | AUPH | Greenleaf Peter | CEO, Dir | A - Grant | — | +667.4K | 1.02M | +192% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | Donley Matthew Maxwell | EVP, Ops, Strategy | A - Grant | — | +271.1K | 403.1K | +205% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | Habig Scott Michael | Chief Commercial Off | A - Grant | — | +170.2K | 312.7K | +119% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | Knappertz Volker | EVP, Research, Development | A - Grant | $0.00 | +191.5K | 344.3K | +125% | $0 | |
| 2023-03-06 | 2023-03-02 | AUPH | Martin Michael Robert | Chief Business Off | A - Grant | — | +107.2K | 259.2K | +71% | — | |
| 2023-03-06 | 2023-03-02 | AUPH | MILNE GEORGE M JR | Dir | P - Purchase | $8.91 | +20.0K | 70.0K | +40% | +$178.2K | |
| 2022-11-23 | 2022-11-21 | AUPH | Donley Matthew Maxwell | Ex VP, Internal Ops | P - Purchase | $4.66 | +10.0K | 27.9K | +56% | +$46.6K | |
| 2022-11-14 | 2022-11-09 | AUPH | Habig Scott Michael | Chief Commercial Off | P - Purchase | $5.02 | +5,000 | 5,000 | New | +$25.1K | |
| 2022-11-09 | 2022-11-07 | AUPH | Martin Michael Robert | Chief Business Off | P - Purchase | $5.16 | +30.0K | 89.5K | +50% | +$154.8K | |
| DA | 2022-07-11 | 2022-05-18 | AUPH | Jayne David R.W. | Dir | M - OptEx | $3.62 | +10.0K | 40.0K | +33% | +$36.2K |
| 2022-03-11 | 2022-03-09 | AUPH | MacKay-Dunn R. Hector | Dir | P - Purchase | $11.00 | +5,000 | 11.0K | +83% | +$55.0K | |
| 2022-03-08 | 2022-03-04 | AUPH | MILNE GEORGE M JR | Dir | P - Purchase | $10.82 | +5,000 | 50.0K | +11% | +$54.1K | |
| D | 2022-03-04 | 2022-03-02 | AUPH | Martin Michael Robert | Chief Business Off | A - Grant | $0.00 | +8,500 | 64.4K | +15% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale | $12.01 | -4,849 | 59.5K | -8% | -$58.2K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Miller Joseph M | CFO | S - Sale | $12.01 | -3,060 | 6,610 | -32% | -$36.8K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Miller Joseph M | CFO | A - Grant | $0.00 | +8,500 | 9,670 | +726% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Huizinga Robert Bindert | EVP of Research | S - Sale | $12.01 | -4,849 | 69.4K | -7% | -$58.2K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Huizinga Robert Bindert | EVP of Research | A - Grant | $0.00 | +8,500 | 74.2K | +13% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Solomons Neil | Chief Medical Off | S - Sale | $12.01 | -4,846 | 91.0K | -5% | -$58.2K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Solomons Neil | Chief Medical Off | A - Grant | $0.00 | +8,500 | 95.8K | +10% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Donley Matthew Maxwell | Ex VP, Intern'l Ops | A - Grant | $0.00 | +8,500 | 19.3K | +79% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Donley Matthew Maxwell | Ex VP, Intern'l Ops | S - Sale | $12.01 | -3,052 | 16.2K | -16% | -$36.7K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Colao Massimilano | Chief Commercial Off | A - Grant | $0.00 | +8,500 | 16.7K | +104% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Colao Massimilano | Chief Commercial Off | S - Sale | $12.01 | -3,205 | 13.5K | -19% | -$38.5K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Greenleaf Peter | CEO, Dir | A - Grant | $0.00 | +28.3K | 42.0K | +206% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Greenleaf Peter | CEO, Dir | S - Sale | $12.01 | -9,068 | 33.0K | -22% | -$108.9K |
| D | 2022-03-04 | 2022-03-02 | AUPH | Robertson Stephen P. | EVP, GC | A - Grant | $0.00 | +8,500 | 11.7K | +267% | $0 |
| D | 2022-01-04 | 2022-01-03 | AUPH | Hagan Joseph P | Dir | M - OptEx | $5.08 | +40.0K | 43.5K | +1,143% | +$203.2K |
| DM | 2022-01-04 | 2022-01-03 | AUPH | Hagan Joseph P | Dir | S - Sale+OE | $22.59 | -40.0K | 3,500 | -92% | -$903.7K |
| 2021-12-15 | 2021-12-13 | AUPH | Leversage Jill | Dir | P - Purchase | $20.04 | +1,600 | 5,300 | +43% | +$32.1K | |
| DM | 2021-11-12 | 2021-11-10+ | AUPH | Solomons Neil | Chief Medical Off | M - OptEx | $5.57 | +200.0K | 157.3K | New | +$1.11M |
| DM | 2021-11-12 | 2021-11-09+ | AUPH | Solomons Neil | Chief Medical Off | S - Sale+OE | $30.03 | -250.0K | 97.3K | -72% | -$7.51M |
| DM | 2021-11-12 | 2021-11-09+ | AUPH | Martin Michael Robert | Chief Business Off | S - Sale+OE | $30.25 | -150.0K | 66.9K | -69% | -$4.54M |
| D | 2021-11-12 | 2021-11-11 | AUPH | Martin Michael Robert | Chief Business Off | M - OptEx | $18.38 | +29.0K | 95.9K | +43% | +$533.0K |
| D | 2021-11-03 | 2021-11-01 | AUPH | Solomons Neil | Chief Medical Off | M - OptEx | $5.30 | +45.0K | 182.3K | +33% | +$238.5K |
| D | 2021-11-03 | 2021-11-01 | AUPH | Solomons Neil | Chief Medical Off | S - Sale+OE | $31.64 | -45.0K | 137.3K | -25% | -$1.42M |
| D | 2021-11-03 | 2021-11-01 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale+OE | $31.64 | -45.0K | 176.9K | -20% | -$1.42M |
| D | 2021-11-03 | 2021-11-01 | AUPH | Martin Michael Robert | Chief Business Off | M - OptEx | $3.20 | +45.0K | 221.9K | +25% | +$144.0K |
| D | 2021-10-26 | 2021-10-25 | AUPH | Huizinga Robert Bindert | EVP of Research | M - OptEx | $3.20 | +95.0K | 195.7K | +94% | +$304.0K |
| D | 2021-10-26 | 2021-10-25 | AUPH | Huizinga Robert Bindert | EVP of Research | S - Sale+OE | $29.75 | -130.0K | 65.7K | -66% | -$3.87M |
| DM | 2021-09-22 | 2021-09-21 | AUPH | Huizinga Robert Bindert | EVP of Research | S - Sale+OE | $23.99 | -32.5K | 100.7K | -24% | -$779.5K |
| DM | 2021-09-22 | 2021-09-21 | AUPH | Huizinga Robert Bindert | EVP of Research | M - OptEx | $2.86 | +27.1K | 122.1K | +29% | +$77.7K |
| DM | 2021-09-22 | 2021-09-20+ | AUPH | Martin Michael Robert | Chief Business Off | M - OptEx | $6.89 | +116.0K | 264.4K | +78% | +$798.8K |
| DM | 2021-09-22 | 2021-09-20+ | AUPH | Martin Michael Robert | Chief Business Off | S - Sale+OE | $23.44 | -116.0K | 176.9K | -40% | -$2.72M |
| DM | 2021-09-16 | 2021-09-14 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale+OE | $21.78 | -44.0K | 206.9K | -18% | -$958.2K |
| D | 2021-09-16 | 2021-09-14 | AUPH | Martin Michael Robert | Chief Business Off | M - OptEx | $5.30 | +44.0K | 220.9K | +25% | +$233.2K |
| D | 2021-09-14 | 2021-09-13 | AUPH | Solomons Neil | Chief Medical Off | M - OptEx | $3.20 | +150.0K | 287.3K | +109% | +$480.0K |
| D | 2021-09-14 | 2021-09-10 | AUPH | Solomons Neil | Chief Medical Off | S - Sale+OE | $19.84 | -150.0K | 137.3K | -52% | -$2.98M |
| DM | 2021-09-14 | 2021-09-10+ | AUPH | Martin Michael Robert | Chief Business Off | S - Sale+OE | $20.89 | -115.0K | 176.9K | -39% | -$2.40M |
| DM | 2021-09-14 | 2021-09-13+ | AUPH | Martin Michael Robert | Chief Business Off | M - OptEx | $4.48 | +115.0K | 201.9K | +132% | +$515.0K |
| M | 2021-09-14 | 2021-09-10+ | AUPH | Huizinga Robert Bindert | EVP of Research | S - Sale | $21.15 | -32.5K | 106.1K | -23% | -$687.3K |
| 2021-09-08 | 2021-09-07 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale | $18.10 | -7,500 | 176.9K | -4% | -$135.8K | |
| 2021-09-08 | 2021-09-07 | AUPH | Huizinga Robert Bindert | EVP of Research | S - Sale | $18.30 | -5,000 | 138.6K | -3% | -$91.5K | |
| 2021-08-27 | 2021-08-26 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale | $17.81 | -22.5K | 184.4K | -11% | -$400.7K | |
| 2021-08-26 | 2021-08-25 | AUPH | Solomons Neil | Chief Medical Off | S - Sale | $15.85 | -5,000 | 137.3K | -4% | -$79.2K | |
| 2021-08-10 | 2021-08-09 | AUPH | Solomons Neil | Chief Medical Off | S - Sale | $16.03 | -45.0K | 142.3K | -24% | -$721.4K | |
| 2021-08-10 | 2021-08-09 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale | $16.01 | -5,000 | 206.9K | -2% | -$80.1K | |
| 2021-07-29 | 2021-07-28 | AUPH | Martin Michael Robert | Chief Business Off | S - Sale | $13.86 | -5,000 | 211.9K | -2% | -$69.3K |
Purchase Sale Sale after option exercise All abbreviations